Stay updated with breaking news from Daniel Vitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
08.06.2022 - Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June 08.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to ... Seite 1
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June 08.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Scientific, Industry and Investor Confer...
Immunic, Inc. (NASDAQ:IMUX – Get Rating) CEO Daniel Vitt purchased 5,000 shares of Immunic stock in a transaction on Friday, June 3rd. The stock was bought at an average price of $3.10 per share, for a total transaction of $15,500.00. Following the completion of the acquisition, the chief executive officer now owns 368,877 shares in […]
Issuer: Immunic, Inc. / Key word(s): Study results Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis